Literature DB >> 9285788

Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family.

J Swensen1, M Hoffman, M H Skolnick, S L Neuhausen.   

Abstract

BRCA1 is a breast and ovarian cancer susceptibility gene. An inferred germline regulatory mutation was previously reported in the BRCA1-linked kindred K2035, based on the absence of transcripts from the BRCA1 allele associated with the cancer susceptibility haplotype. In this study, the promoter region of BRCA1 was examined in individuals from K2035 for evidence of a mutation which could halt transcription. Evaluation of a polymorphism located within intron 2 of BRCA1 gave results consistent with the presence of a large deletion in K2035 mutation carriers. Southern blot analysis identified unique restriction fragments which occurred as a result of a 14 kb deletion that removed both of BRCA1's transcription start sites (exons 1a and 1b) as well as exon 2. Sequencing indicated that unequal crossover between Alu repeats was the likely cause of the deletion. Similar deletions may be responsible for other reported inferred regulatory mutations, as well as unidentified mutations in families linked to BRCA1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285788     DOI: 10.1093/hmg/6.9.1513

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  22 in total

1.  The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. The BRCA1 Exon 13 Duplication Screening Group.

Authors: 
Journal:  Am J Hum Genet       Date:  2000-05-25       Impact factor: 11.025

Review 2.  Expression of BRCA1 and BRCA2 in normal and neoplastic cells.

Authors:  L A Chodosh
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

3.  Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot.

Authors:  Nadine Puget; Sophie Gad; Laure Perrin-Vidoz; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Gilbert M Lenoir; Sylvie Mazoyer
Journal:  Am J Hum Genet       Date:  2002-03-05       Impact factor: 11.025

4.  Characterization of Alu and recombination-associated motifs mediating a large homozygous SPG7 gene rearrangement causing hereditary spastic paraplegia.

Authors:  Eva López; Carlos Casasnovas; Javier Giménez; Antoni Matilla-Dueñas; Ivelisse Sánchez; Víctor Volpini
Journal:  Neurogenetics       Date:  2014-11-16       Impact factor: 2.660

5.  High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects.

Authors:  G Goelen; E Teugels; M Bonduelle; B Neyns; J De Grève
Journal:  J Med Genet       Date:  1999-04       Impact factor: 6.318

6.  BRCA2 T2722R is a deleterious allele that causes exon skipping.

Authors:  James D Fackenthal; Luca Cartegni; Adrian R Krainer; Olufunmilayo I Olopade
Journal:  Am J Hum Genet       Date:  2002-07-19       Impact factor: 11.025

7.  The BRCA1 exon 13 duplication in the Swedish population.

Authors:  Barbara Kremeyer; Maria Soller; Kristina Lagerstedt; Paula Maguire; Sylvie Mazoyer; Margareta Nordling; Jan Wahlström; Annika Lindblom
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

Review 8.  An alternative approach to medical genetics based on modern evolutionary biology. Part 4: HERVs in cancer.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-11       Impact factor: 5.344

9.  Identification of intragenic deletions and duplication in the FLCN gene in Birt-Hogg-Dubé syndrome.

Authors:  Jihane N Benhammou; Cathy D Vocke; Avni Santani; Laura S Schmidt; Masaya Baba; Kuniaki Seyama; Xiaolin Wu; Susana Korolevich; Katherine L Nathanson; Catherine A Stolle; W Marston Linehan
Journal:  Genes Chromosomes Cancer       Date:  2011-03-15       Impact factor: 5.006

10.  Quantifying the mechanisms for segmental duplications in mammalian genomes by statistical analysis and modeling.

Authors:  Yi Zhou; Bud Mishra
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.